Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) FCF Margin (2019 - 2023)

Benitec Biopharma's FCF Margin history spans 5 years, with the latest figure at 58514.29% for Q2 2023.

  • For Q2 2023, FCF Margin changed N/A year-over-year to 58514.29%; the TTM value through Mar 2024 reached 288657.14%, down 26103214.0%, while the annual FY2023 figure was 24017.33%, 222007.0% down from the prior year.
  • FCF Margin for Q2 2023 was 58514.29% at Benitec Biopharma, down from 7438.89% in the prior quarter.
  • Across five years, FCF Margin topped out at 7702.44% in Q2 2020 and bottomed at 351400.0% in Q4 2020.
  • The 5-year median for FCF Margin is 7438.89% (2023), against an average of 71895.8%.
  • The largest annual shift saw FCF Margin plummeted -34740519bps in 2020 before it skyrocketed 33820000bps in 2021.
  • A 5-year view of FCF Margin shows it stood at 3994.81% in 2019, then crashed by -8696bps to 351400.0% in 2020, then surged by 96bps to 13200.0% in 2021, then crashed by -217bps to 41821.43% in 2022, then crashed by -40bps to 58514.29% in 2023.
  • Per Business Quant, the three most recent readings for BNTC's FCF Margin are 58514.29% (Q2 2023), 7438.89% (Q1 2023), and 41821.43% (Q4 2022).